We have previously identified two gCNVs namely CNV-30450 in MAPKAPK2 and CNV-3956 in CHRNA7 as prognostic biomarkers for lung cancer survival based on candidate gene study design (Liu et al., 2012; Yang et al., 2015b). This evidence concerns the gene MAPKAPK2 and lung cancer.